96
Participants
Start Date
May 8, 2024
Primary Completion Date
February 12, 2025
Study Completion Date
May 8, 2025
Bupivacaine Liposome 13.3 Milligrams/Milliliter [Exparel]
Bupivacaine liposome is a multivesicular formulation of bupivacaine that allows rapid absorption and prolonged release of bupivacaine.
Dexmedetomidine 0.5milligram (50micrograms)
Dexmedetomidine is a full α₂ adrenergic receptor agonist roughly eight times more selective for the α₂ receptor than clonidine.
The University of Hong Kong, Hong Kong
The University of Hong Kong
OTHER